Cite Filings / SABS / 0000950170-23-054396

Feed Companies Filings Check

Sign in

PRE 14A

Proxy Statement (Preliminary)

SAB Biotherapeutics, Inc. Filed 2023-10-20 Acc 0000950170-23-054396

Documents 1

PRE 14A Proxy Statement (Preliminary) , sabs_pre14a_fy23_spec_me.htm

Around this filing

2023-12-08 PRE 14A Proxy Statement (Preliminary)
2023-10-27 8-K Material agreement · Executive or director change
2023-10-24 4 Options or other derivatives
2023-10-24 4 Options or other derivatives
2023-10-20 PRE 14A Proxy Statement (Preliminary)
2023-10-16 SC 13G Amended Statement of Ownership
2023-10-16 D Notice of Sales of Unregistered Securities

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading sabs_pre14a_fy23_spec_me.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…